Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...

Semaglutide shows promise in MASH treatment, achieving significant MASH resolution and fibrosis improvement in the ESSENCE trial. Tolerability issues and insurance coverage challenges lead to 20% ...

Now, according to leaked documents, Ducati is planning to plonk this engine into the DesertX and Monster models as well, starting in 2026. Ducati Monster, DesertX to be powered by the new 890cc V2 ...

Altimmune, Inc. announced new analyses at the EASL Congress in Amsterdam, showcasing the MASH Resolution Index (MASHResInd) algorithm, developed by Dr. Rohit Loomba, to predict resolution in ...

Hawthorn, the adorable sandbox RPG headed by talent who worked on Skyrim and other big RPG titles, has been up on Kickstarter for just one day – but it's already raised over $100,000. The ...

Both feature the same ruleset, the same compulsive loop and the same stratospheric levels of production quality, with gigantic monster miniatures that tower above the hunters for an awesome sense ...

AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...